
ALK-Positive Cancer Targeted Therapy
ALK-positive cancer targeted therapy in India with validated molecular testing, disease-specific oncology review, ALK-inhibitor selection and monitoring for response, resistance and side effects.
Related Conditions
Our services are FREE and by using our services your hospital bill does not increase!
About ALK-Positive Cancer Targeted Therapy
ALK-positive cancer targeted therapy in India uses medicines that inhibit abnormal ALK signalling when a clinically relevant ALK rearrangement or other actionable alteration has been confirmed. It is most established in ALK-positive non-small-cell lung cancer, although ALK alterations occur in some other cancers and treatment must follow the evidence for that specific tumour type. A positive molecular result does not by itself determine the drug: cancer type, stage, previous therapy, sites of disease and resistance findings all matter.
Before treatment, patients usually need pathology review and validated ALK testing, which may use immunohistochemistry, FISH, PCR or next-generation sequencing depending on the tumour and laboratory. Staging imaging, including brain imaging when relevant, helps define disease extent. If cancer progresses during an ALK inhibitor, the oncology team may review adherence, sites of progression and repeat tissue or liquid-biopsy testing where clinically useful to look for resistance mechanisms and guide the next treatment strategy.
ALK inhibitors can have different adverse-effect profiles and drug interactions, so treatment requires oncology follow-up and appropriate laboratory or imaging monitoring. New severe breathlessness, jaundice, fainting, marked neurological symptoms or other acute deterioration during cancer treatment requires prompt local medical assessment rather than waiting for an overseas consultation.
Cost in India depends mainly on the specific ALK inhibitor, branded versus available alternative formulations, dose and duration, molecular testing, imaging and oncology follow-up. Tertiary cancer centres in India can provide thoracic or disease-specific medical oncologists, molecular pathology, multidisciplinary tumour-board review and monitoring during targeted therapy. Medical Help India can connect international patients with a suitable healthcare partner to review pathology, molecular reports, staging scans and previous treatment, assess appropriate ALK-directed options and obtain an individual treatment estimate.
What's Included
Why consider treatment in India?
Access to experienced specialists
Advanced treatment and diagnostic options
More affordable hospital care
Shorter waiting times for treatment
Help comparing hospitals, plans and costs
Support with appointments, travel and follow-up
Cost in India
USDFinal costs depend on the medical assessment, hospital, room category and clinical needs.
How it works
Share your details
Tell us about your health concerns, age and current location.
Receive a call
We call you to discuss your situation, needs and questions.
Receive a treatment plan
Get information about the most suitable treatment plan, hospital and estimated cost.
Choose your plan
Review the options and agree on your care and travel plan.
Get full support
Receive full support throughout every stage of your care journey.
Receive care in India
Receive your planned care with support throughout your stay.
Top Hospitals for ALK-Positive Cancer Targeted Therapy
View All Hospitals →Top Doctors for ALK-Positive Cancer Targeted Therapy
View All Doctors →Frequently Asked Questions
How much does ALK-Positive Cancer Targeted Therapy cost in India?
Costs depend mainly on the specific ALK inhibitor, dose and expected treatment duration, molecular testing, imaging and oncology follow-up. If treatment changes because of progression or resistance, the next medicine and any repeat tissue or liquid-biopsy testing should be estimated separately.
Which medical reports are useful to have ready for ALK-Positive Cancer Targeted Therapy?
Have ready: the pathology report, ALK and other molecular-testing reports, staging scans, brain imaging when performed, previous oncology-treatment summaries and a current medicine list. If disease has progressed on an ALK inhibitor, include the treatment timeline, latest scans and any repeat tissue or liquid-biopsy results.
How is ALK positivity confirmed?
ALK status is confirmed using tumour molecular testing, which may include immunohistochemistry, FISH, PCR or next-generation sequencing depending on the cancer type and laboratory.
Is ALK-targeted therapy the same for every cancer?
No. The appropriate medicine depends on the cancer type, molecular alteration, disease stage, previous treatment and other clinical factors.
Can an existing molecular report be reviewed for a second opinion?
Yes. An oncologist can review the pathology, molecular report, imaging and prior treatment history to confirm whether ALK-directed treatment is appropriate.

Our services are FREE
We connect you with leading hospitals and specialists in India. You pay the hospital directly.


